Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'Pharmacovigilance-Study'
Pharmacovigilance-Study published presentations and documents on DocSlides.
Pharmacovigilance: challenges facing WHO
by debby-jeon
Shanthi Pal. Leader, Medicines Safety. Safety . a...
Introduction to pharmacovigilance
by ellena-manuel
Monitoring the safety of medicines. Pharmacovigil...
Pharmacovigilance: challenges facing WHO
by celsa-spraggs
Shanthi Pal. Leader, Medicines Safety. Safety . a...
Pharmacovigilance 1 Dr. Ganesh Uchit
by liane-varnes
, MD. Pfizer, India. DISCLAIMER. Overview. Intr...
Social Pharmacy and Pharmacovigilance
by debby-jeon
JAMASOFT2017. 1. Social. Pharmacy. Pharmacoepide...
Aspects of pharmacovigilance: Public hearings
by sean858
A public hearing is a forum to which the public is...
Pharmacovigilance and drug safety trainings to increase Tuberculosis (TB) preventive treatment (TPT
by karsyn769
Authors: . 1. Juliet Jokwiro, . 1. Nicole Chekuda...
Vaccine Pharmacovigilance
by mia
Definition- . According to the CIOMS/WHO working g...
Principles of Risk Management
by desha
No medicine is without . risk and the. . benefi...
Clin Pract
by blanko
1466 Nikhil GuptaKavita BahmaniAjit Jangra Introdu...
Prospects and Challenges of Providing
by mitsue-stanley
Prospects and Challenges of Providing Pharmacovi...
Prospects and Challenges of Providing
by mitsue-stanley
Prospects and Challenges of Providing Pharmacovi...
Pharmacovigilance: New challenges for WHO
by pamella-moone
Dr Shanthi Pal. . Group Lead, Medicines Safety ....
Introduction to Pharmacovigilance
by lindy-dunigan
& . Adverse Drug Reactions . Reporting system...
Toolkit for research and development of paediatric antiretroviral drugs and formulations
by luanne-stotts
Module 10:. Pharmacovigilance. Background – def...
Pharmacovigilance:
by kittie-lecroy
New challenges for WHO. Dr Shanthi Pal. . Group ...
Post Market Surveillance
by alida-meadow
KNH/UON . Pharmacy Symposium. Optimizing Medicine...
Pharmacovigilance:
by lois-ondreau
New challenges for WHO. Dr Shanthi Pal. . Group ...
International Nonproprietary
by amber
N. ames. Contents . General Introduction . Element...
Medication errors within PV Centers
by SexyBeast
Pr. . Rachida. . Soulaymani. . Bencheikh. Centre...
Off-label Use Off-label use of medicines is
by karlyn-bohler
NOT. regulated by EU legislation and no uniform ...
About OMICS Group OMICS Group is an amalgamation of
by phoebe-click
Open Access Publications. and worldwide internat...
Benefits of a strong collaboration with patient groups
by min-jolicoeur
at national . and EU level. Susanna Palkonen, Dir...
The GVS blueprint and its implementation
by alexa-scheidler
. Dr Madhava Ram. Medical Officer. EMP/ SAV. Uns...
8 September 2014EMA//2011Rev 1*Guideline on good pharmacovigilance pra
by giovanna-bartolotta
Draft Revision 1 agreed by ERMS FG29 May 2013 Draf...
September EMA Inspections and Human Medicines Pharmacovigilance D ivision Questions answers on signal management This document addresses a number of questions which stakeholders in particular marke
by alida-meadow
If you have a question on signal managem ent that...
JanuaryEMA/118465/2012Guideline on good pharmacovigilance practice(GVP
by faustina-dinatale
Draft agreed by ERMS FG20 July 2012 Draft adopted ...
Guideline on good pharmacovigilance practices (GVP)Module II Pharmacov
by pasty-toler
9 April EMA/816573/2011Rev 1* Draft agreed by ERM...
Load More...
